Issue 3, 2022

Bifunctional chelators for radiorhenium: past, present and future outlook

Abstract

Targeted radionuclide therapy (TRNT) is an ever-expanding field of nuclear medicine that provides a personalised approach to cancer treatment while limiting toxicity to normal tissues. It involves the radiolabelling of a biological targeting vector with an appropriate therapeutic radionuclide, often facilitated by the use of a bifunctional chelator (BFC) to stably link the two entities. The radioisotopes of rhenium, 186Re (t1/2 = 90 h, 1.07 MeV β, 137 keV γ (9%)) and 188Re (t1/2 = 16.9 h, 2.12 MeV β, 155 keV γ (15%)), are particularly attractive for radiotherapy because of their convenient and high-abundance β-particle emissions as well as their imageable γ-emissions and chemical similarity to technetium. As a transition metal element with multiple oxidation states and coordination numbers accessible for complexation, there is great opportunity available when it comes to developing novel BFCs for rhenium. The purpose of this review is to provide a recap on some of the past successes and failings, as well as show some more current efforts in the design of BFCs for 186/188Re. Future use of these radionuclides for radiotherapy depends on their cost-effective availability and this will also be discussed. Finally, bioconjugation strategies for radiolabelling biomolecules with 186/188Re will be touched upon.

Graphical abstract: Bifunctional chelators for radiorhenium: past, present and future outlook

Article information

Article type
Review Article
Submitted
11 נוב 2021
Accepted
14 ינו 2022
First published
14 ינו 2022

RSC Med. Chem., 2022,13, 217-245

Bifunctional chelators for radiorhenium: past, present and future outlook

D. R. Melis, A. R. Burgoyne, M. Ooms and G. Gasser, RSC Med. Chem., 2022, 13, 217 DOI: 10.1039/D1MD00364J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements